PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'EpicentRx, Inc., La Jolla, CA, USA. Electronic address: boronsky@epicentrx.com.\', \'Stanford University, Stanford, CA, USA.\', \'University of California San Diego, La Jolla, CA, USA.\', \'InterWest Partners, Menlo Park, CA, USA.\', \'EpicentRx, Inc., La Jolla, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0093-7754(20)30079-810.1053/j.seminoncol.2020.07.002
?:hasPublicationType
?:journal
  • Seminars in oncology
is ?:pmid of
?:pmid
?:pmid
  • 32718560
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.099
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all